The latest closing stock price for Neuphoria Therapeutics as of May 16, 2025 is 4.92.
An investor who bought $1,000 worth of Neuphoria Therapeutics stock at the IPO in 2021 would have $-972 today, roughly -1 times their original investment - a -69.69% compound annual growth rate over 3 years.
The all-time high Neuphoria Therapeutics stock closing price was 176.76 on December 16, 2021.
The Neuphoria Therapeutics 52-week high stock price is 15.25, which is 210% above the current share price.
The Neuphoria Therapeutics 52-week low stock price is 2.12, which is 56.9% below the current share price.
The average Neuphoria Therapeutics stock price for the last 52 weeks is 5.87.
An investor who bought $1,000 worth of Neuphoria Therapeutics stock at the IPO in 2021 would have $-972 today, roughly -1 times their original investment - a -69.69% compound annual growth rate over 3 years.
The all-time high Neuphoria Therapeutics stock closing price was 176.76 on December 16, 2021.
The Neuphoria Therapeutics 52-week high stock price is 15.25, which is 210% above the current share price.
The Neuphoria Therapeutics 52-week low stock price is 2.12, which is 56.9% below the current share price.
The average Neuphoria Therapeutics stock price for the last 52 weeks is 5.87.